Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Spectrum Pharmaceuticals Receives Complete Response Letter from U.S. Food and Drug Administration for Poziotinib; Reaffirms Focus on the Commercialization of ROLVEDON
Saturday, November 26, 2022Spectrum Pharmaceuticals Inc a biopharmaceutical company focused on novel and targeted oncology therapies today announced that the Company has received a Complete Response Letter CRL from the US Food and Drug Administration FDA regarding Spectrums Ne...
Junshi Biosciences Announces Submission of a Marketing Authorization Application for Toripalimab to the UK Medicines and Healthcare Products Regulatory Agency
Thursday, November 24, 2022Shanghai Junshi Biosciences Co Ltd a leading innovationdriven biopharmaceutical company dedicated to the discovery development and commercialization of novel therapies announced today that the company has submitted a marketing authorization applicati...
Mabwell Announces the U.S. FDA approval of 9MW3011 (FIC) for IND
Thursday, November 24, 2022Mabwell an innovative biopharmaceutical company with the layout of whole industry chain announced that its clinical trial application for MW Injection used in patients with polycythemia vera was formally approved by the United States Food and Drug Ad...
Tretinoin Creams in the UK Expands Inventory, Launching Tretinoin Cream 0.05 and Tretinoin Cream 0.1
Wednesday, November 23, 2022Tretinoin Creams UK based pharmaceutical company has expanded its inventory The new product range is Tretinoin Cream Tretinoin Cream and the lower strength Tretinoin Cream version Their Tretinoin creams in the UK have gained great popularity Also...
Sintalica Bioscience Announces Key Approval Milestones from the Italian Health Authority
Wednesday, November 23, 2022Sintalica Bioscience Corp a psychedelic drug discovery company focused on breakthrough treatments for neuroinflammatory disorders
U.S. Food and Drug Administration approves CSL's HEMGENIX® (etranacogene dezaparvovec-drlb), the first gene therapy for hemophilia B
Tuesday, November 22, 2022Global biotechnology leader CSL announced that the US Food and Drug Administration FDA approved HEMGENIX etranacogene dezaparvovecdrlb the first and only onetime gene therapy for appropriate adults with hemophilia B HEMGENIX is approved for the treat...
Teva Finalizes Nationwide Opioid Settlement Terms
Tuesday, November 22, 2022Teva Pharmaceuticals a US affiliate of Teva Pharmaceutical Industries Ltd announced today that the company has finalized the documentation of its proposed nationwide opioid settlement with both the working group of States Attorneys General and the Mu...
Nirvana Life Sciences Inc. announces agreement to acquire the licensed distributor of a Patented, WHO approved, herbal treatment for opiate addiction
Monday, November 21, 2022Nirvana Life Sciences Inc a western Canadian based life sciences company aimed at developing psychedelic and other natural based medicines including nonaddictive chronic pain and relapse preventing pharmaceutical medicines is pleased to report that i...
Genmab Announces U.S. Food and Drug Administration Accepts for Priority Review Biologics License Application (BLA) for Epcoritamab (DuoBody®-CD3xCD20)
Monday, November 21, 2022Genmab AS announced that the US Food and Drug Administration FDA has accepted for Priority Review the Biologics License Application BLA for subcutaneous epcoritamab DuoBodyCDxCD an investigational bispecific antibody for the treatment of patients wit...
Oramed Announces Additional Positive Safety and Efficacy Data from Its Phase 2 Clinical Trial of ORMD-0801 for NASH
Thursday, November 17, 2022Oramed Pharmaceuticals Inc a clinicalstage pharmaceutical company focused on the development of oral drug delivery platforms today announced additional positive data from its Phase doubleblind fully randomized placebocontrolled multicenter clinical...
